Strata Critical Medical, Inc.
SRTANasdaqHealthcare · Services-Health Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $197.1M | $248.7M | $225.2M | $146.1M | $50.5M | $23.4M |
| Operating income | −$22.4M | −$33.9M | −$68.1M | −$53.5M | −$24.1M | −$10.4M |
| Net income | $41.3M | −$27.3M | −$56.1M | −$27.3M | −$40.1M | −$10.2M |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $335.9M | $17.7M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $44.5M | $6.6M |
| Equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.4M | $11.1M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 | $-0.40 |
| Shares out. | 79.7M | 75.4M | 72.0M | 71.2M | 70.6M | 25.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −11.3%
- Net margin
- 21.0%
- Return on equity
- 14.8%
- Return on assets
- 12.7%
- Return on capital (ROCE)
- −7.3%
- Liabilities / assets
- 14.3%
- Debt / equity
- 0.17×
- Book value / share
- $3.50
- Revenue growth (YoY)
- −20.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.54safe
- Accruals / assets
- 27.7%high accruals
- Beneish M-Score
- 0.21elevated
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 2 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
- Beneish M-Score elevated — earnings-manipulation screen flag
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Krstic VeliborActivist (13D)May 8, 2026
- Ark Investment Management LlcPassive (13G)Apr 30, 2026
- Blackrock, Inc.Passive (13G)Jan 21, 2026
- Third Point LlcPassive (13G)Nov 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Cohen AmirOfficer — Chief Accounting Officer | May 21, 2026 | Sell | 10,300 | $5.79 |
| Cohen AmirOfficer — Chief Accounting Officer | May 11, 2026 | Sell | 14,306 | $5.79 |
| Wunsch Scott MOfficer — CEO, Logistics | Apr 23, 2026 | Grant | 57,172 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 6.9M | 6.0 | +7.5% |
| Apr 30, 2026 | 6.4M | 9.4 | +8.3% |
| Apr 15, 2026 | 5.9M | 9.3 | -20.4% |
| Mar 31, 2026 | 7.4M | 10.8 | +12.9% |
| Mar 13, 2026 | 6.6M | 6.3 | +18.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 6, 2026
- Results of operationsMar 3, 2026
- Entered a material agreement · Regulation FD disclosureFeb 5, 2026
- Director / officer change · Regulation FD disclosureDec 3, 2025
- Results of operationsNov 10, 2025
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Regulation FD disclosureSep 16, 2025
- Entered a material agreement · Completed an acquisition or disposition · Director / officer change · Amended charter or bylaws · Regulation FD disclosure · Other material eventAug 29, 2025
- Results of operationsAug 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4FORM 4May 26, 2026
- 4FORM 4May 13, 2026
- 144May 11, 2026
- SCHEDULE 13D/AMay 8, 2026
- 4PRIMARY DOCUMENTMay 8, 2026
- 25-NSEMay 6, 2026
- 10-QMay 6, 2026
- 8-KMay 6, 2026
- SCHEDULE 13G/AApr 30, 2026
- 4FORM 4Apr 27, 2026
- 4FORM 4Apr 27, 2026
- 4FORM 4Apr 27, 2026
- 4FORM 4Apr 27, 2026
- SCHEDULE 13D/AApr 16, 2026
- DEFA14AApr 14, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.